Data protection Impressum

Healthcare

The Foundation for Innovation and Technology has awarded five Tech Grants of CHF 100,000 each to projects from the canton of Vaud: three FIT-InnoTREK grants to Chorus Tre, HeteroSight and SixtineAI, all arising from the CHUV, and two FIT-Innogrant grants to Cookd Labs and Endobotica, both from EPFL.

FIT awards five Tech Grants to projects from the CHUV and EPFL

7 September 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (August 2026)

31 August 2026

An interdisciplinary team from the University of Bern and Inselspital has developed CARESCORE, an AI model that calculates a patient's individual risk of postoperative infection within seconds of surgery ending, by drawing on vital signs recorded during the procedure.

Bern researchers develop an AI model that predicts infection risk at the end of surgery

31 August 2026

The Foundation for Innovation and Technology has awarded a CHF 200,000 Digital Growth loan to WasteFlow, CHF 50,000 Digital Seed loans to DOCumenter and Nextrainers, and a CHF 20,000 Digital Grant to RiveLock.

FIT supports four Vaud start-ups through its Digital programs

31 August 2026

Distalmotion, the Lausanne-based medtech company, has received FDA 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System, completing its portfolio for the four highest-volume outpatient soft tissue procedures in the United States.

Distalmotion’s DEXTER robot cleared by the FDA for ventral hernia repair

20 August 2026

Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.

Spineart receives FDA approval for its BAGUERA C cervical disc

20 August 2026

Bewe, a University of Fribourg spin-off developing a neuroscience-based digital intervention for unhealthy food cravings, has been awarded Biopôle's Pre-Clinical Top-Up, a CHF 250,000 convertible loan supporting start-ups facing high clinical validation costs.

Bewe awarded the Biopôle Pre-Clinical Top-Up for its digital therapy against food cravings

20 August 2026

A new study conducted at Bern’s University Hospital shows that VisionOne, the virtual reality eye-testing platform developed by Vaud-based PeriVision, delivers clinical performance comparable to the stationary perimeter considered the gold standard, including in advanced glaucoma.

PeriVision’s VR eye test matches the gold standard across glaucoma severity

17 August 2026

Oculis, the Lausanne-based biopharmaceutical company focused on ophthalmology and neuro-ophthalmology, will acquire all worldwide development and commercial rights to Privosegtor from Accure, terminating its existing license agreement.

Oculis acquires worldwide rights to its Privosegtor candidate

17 August 2026

Researchers at EPFL, with colleagues from the University of Geneva, Geneva University Hospitals and Zurich, have developed VirTues, an AI foundation model for tissue biology that analyzes tumor tissue across many cancer types, with results published in Nature.

EPFL’s VirTues AI model maps tumor tissue across cancer types

17 August 2026

1 2 3 4 5 … 24